Frequency of genetic testing of patients with ovarian, fallopian tube, and primary peritoneal cancers: Quality improvement initiative

被引:0
|
作者
Nawlo, Jude [1 ]
Espino, Kevin [1 ]
Gerber, Deanna [2 ]
Chan, Kent [2 ]
Jimenez, Edward [2 ]
Chalas, Eva [2 ]
机构
[1] NYU Langone Long Isl Hosp, Mineola, NY USA
[2] NYU Langone Hosp Long Isl, Brooklyn, NY USA
关键词
D O I
10.1016/j.ygyno.2023.06.343
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
2224
引用
收藏
页码:S270 / S271
页数:2
相关论文
共 50 条
  • [41] The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer
    F. Zeppernick
    I. Meinhold-Heerlein
    Archives of Gynecology and Obstetrics, 2014, 290 : 839 - 842
  • [42] The new FIGO staging system for ovarian, fallopian tube, and primary peritoneal cancer
    Zeppernick, F.
    Meinhold-Heerlein, I.
    ARCHIVES OF GYNECOLOGY AND OBSTETRICS, 2014, 290 (05) : 839 - 842
  • [43] Laparoscopic cytoreduction for primary advanced or recurrent ovarian, fallopian tube, and peritoneal malignancies
    Nezhat, F. R.
    GYNECOLOGIC ONCOLOGY, 2008, 108 (03) : S60 - S61
  • [44] Niraparib for the Treatment of Recurrent Epithelial Ovarian, Fallopian Tube, or Primary Peritoneal Cancer
    Kerliu, Lloreta
    Myruski, Samantha
    Bhatti, Afeefa
    Soni, Priyal
    Petrosius, Paulius
    Pervanas, Helen C.
    Horton, Evan R.
    ANNALS OF PHARMACOTHERAPY, 2020, 54 (10) : 1010 - 1015
  • [45] The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications
    Duska, L. R.
    Kohn, E. C.
    ANNALS OF ONCOLOGY, 2017, 28 : 8 - 12
  • [46] Epothilones in epithelial ovarian, fallopian tube, or primary peritoneal cancer: a systematic review
    Zagouri, Flora
    Sergentanis, Theodoros N.
    Chrysikos, Dimosthenis
    Dimopoulos, Meletios-Athanassios
    Bamias, Aristotle
    ONCOTARGETS AND THERAPY, 2015, 8 : 2187 - 2198
  • [47] NEW MAINTENANCE TREATMENT FOR RECURRENT OVARIAN, FALLOPIAN TUBE, OR PRIMARY PERITONEAL CANCER
    Aschenbrenner, Diane S.
    AMERICAN JOURNAL OF NURSING, 2018, 118 (08) : 25 - 26
  • [48] Benefits of neoadjuvant chemotherapy in ovarian, primary peritoneal, or fallopian tube carcinoma.
    Brown, Alaina J.
    Huang, Marilyn
    Sun, Charlotte C.
    Zaid, Tarrik M.
    Balakrishnan, Nyla
    Mhadgut, Hemendra
    Lu, Karen H.
    Westin, Shannon Neville
    Bodurka, Diane C.
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [49] Eriotinib (E) in combination with docetaxel (D) and carboplatin (C): a phase Ib trial in patients with untreated ovarian, fallopian tube and primary peritoneal cancers
    Agarwal, R.
    Kaye, S.
    Vasey, P.
    Paul, J.
    Gore, M.
    Wilson, R.
    Rustin, G.
    Gabra, H.
    Guastalla, J. -P
    Carty, K.
    ANNALS OF ONCOLOGY, 2004, 15 : 127 - 127
  • [50] Germline mutations in Black women with ovarian, fallopian tube and primary peritoneal carcinomas
    Somasegar, Sahana
    Weiss, Arielle
    Norquist, Barbara
    Khasnavis, Nithisha
    Radke, Marc
    Manhardt, Enna
    Pennil, Christopher
    Pennington, Kathryn
    Eckert, Mark
    Chryplewicz, Agnieszka
    Lengyel, Ernst
    Swisher, Elizabeth
    GYNECOLOGIC ONCOLOGY, 2022, 164 (01) : E32 - E32